Introducing LamiPro, A Breakthrough HFpEF Therapy

LamiHeart is poised to disrupt the massive $26 billion heart failure market with LamiPro, a novel biologic targeting HFpEF (heart failure with preserved ejection fraction), also known as diastolic heart failure.

What we do

We are developing the first curative treatment for heart failure with preserved ejection fraction (HFpEF). Our innovative biologic therapy aims to transform the lives of millions affected by this challenging cardiovascular condition, offering hope where current treatments fall short.

fi_8001247

The Problem

Today there are currently 13 million healthcare accessible patients with HFpEF globally, growing to 34 million by 2030.
No highly effective treatments currently exist for HFpEF. Medications that treat HFrEF, including ACE inhibitors and beta blockers, have failed to improve outcomes in HFpEF patients.

fi_8001247

Our Solution

Introducing LamiPro, A Novel HFpEF Therapy. LamiPro is an innovative biopolymer uniquely designed to target the underlying dysfunction in HFpEF. Inspired by natural proteins in the heart, LamiPro is designed to integrate into the injured heart to repair damage and restore normal function.

fi_8001247

Market Opportunity

Massive Addressable Market: The HFpEF market is anticipated to grow to 34 million by 2030, and represents a multi-billion dollar opportunity. In the US, total annual costs associated with HFpEF are estimated at over $30 billion. Mean annual costs per HFpEF patient are $28,000, with over 70% attributable to hospitalizations.

Our Brains

The Pioneering Minds Behind the Revolution. At the core of Lami Heart’s groundbreaking progress stand two unparalleled figures: Dr. Doris Taylor and Dr. Luiz Sampaio. Together, their combined prowess makes Lami Heart a beacon of hope and progress in the world of medical science.

Ellipse

Dr. Doris Taylor

Scientist, Entrepreneur

Dr. Taylor is an innovative scientist, entrepreneur, and global thought leader in regenerative medicine. She has published ~200 papers, holds over 30 patents, and is the founder of multiple companies.

.iconz-container { display: flex; justify-content: center; /* Center horizontally */ align-items: center; /* Center vertically */ } .icon { margin: 0 12px; padding: 8px; background-color: #8A8A7B1A; border-radius: 8px; border-radius: 8px!important; width: 40px; height: 40px!important; }
Ellipse

Dr. Luiz Sampaio

MD, MSc

Dr. Luiz Sampaio is a cardiovascular surgeon, scientist, and entrepreneur with broad experience in academia, private practice, and the medical industry.

.iconz-container { display: flex; justify-content: center; /* Center horizontally */ align-items: center; /* Center vertically */ } .icon { margin: 0 12px; padding: 8px; background-color: #8A8A7B1A; border-radius: 8px; border-radius: 8px!important; width: 40px; height: 40px!important; }

Contact us

Want to know more? Contact us today.